Prelude Therapeutics, Inc. (PRLD)
3.74
-0.15
(-3.86%)
USD |
NASDAQ |
Oct 12, 16:00
3.75
+0.01
(+0.27%)
After-Hours: 20:00
Prelude Therapeutics Max Drawdown (5Y) : 99.33% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.33% |
| August 31, 2026 | 99.33% |
| July 31, 2026 | 99.33% |
| June 30, 2026 | 99.33% |
| May 31, 2026 | 99.33% |
| April 30, 2026 | 99.33% |
| March 31, 2026 | 99.33% |
| February 28, 2026 | 99.33% |
| January 31, 2026 | 99.33% |
| December 31, 2025 | 99.33% |
| November 30, 2025 | 99.33% |
| October 31, 2025 | 99.33% |
| September 30, 2025 | 99.33% |
| August 31, 2025 | 99.33% |
| July 31, 2025 | 99.33% |
| June 30, 2025 | 99.33% |
| May 31, 2025 | 99.33% |
| April 30, 2025 | 99.33% |
| March 31, 2025 | 99.30% |
| February 28, 2025 | 99.19% |
| January 31, 2025 | 99.13% |
| December 31, 2024 | 99.13% |
| November 30, 2024 | 98.97% |
| October 31, 2024 | 98.69% |
| September 30, 2024 | 98.16% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.16% |
| July 31, 2024 | 98.16% |
| June 30, 2024 | 98.16% |
| May 31, 2024 | 98.16% |
| April 30, 2024 | 98.16% |
| March 31, 2024 | 98.16% |
| February 29, 2024 | 98.16% |
| January 31, 2024 | 98.16% |
| December 31, 2023 | 98.16% |
| November 30, 2023 | 98.16% |
| October 31, 2023 | 98.16% |
| September 30, 2023 | 97.01% |
| August 31, 2023 | 96.40% |
| July 31, 2023 | 95.74% |
| June 30, 2023 | 95.64% |
| May 31, 2023 | 95.64% |
| April 30, 2023 | 95.64% |
| March 31, 2023 | 95.64% |
| February 28, 2023 | 95.64% |
| January 31, 2023 | 95.64% |
| December 31, 2022 | 95.64% |
| November 30, 2022 | 95.64% |
| October 31, 2022 | 95.64% |
| September 30, 2022 | 95.64% |
| August 31, 2022 | 95.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Q32 Bio, Inc. | 99.58% |
| Intellia Therapeutics, Inc. | 96.45% |
| Twist Bioscience Corp. | 94.48% |
| Beam Therapeutics, Inc. | 89.12% |
| Revolution Medicines, Inc. | 73.29% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.50 |
| Beta (5Y) | 0.9695 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.36% |
| Historical Sharpe Ratio (5Y) | -0.3922 |
| Historical Sortino (5Y) | -0.7974 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.00% |